Safety and efficacy of new drugs in Chronic Myeloid Leukemia
Prognostic factors and biomarkers in Chronic Myeloid
Leukemia
Resistance to tyrosine kinase inhibitors in Chronic Myeloid
Leukemia
Characterization of BCR-ABL positive leukemia stem cells and
development of new strategies for the eradication of minimal
residual disease